CY1308A
(en)
|
1979-12-06 |
1985-12-06 |
Glaxo Group Ltd |
Device for dispensing medicaments
|
US4353656A
(en)
|
1980-10-14 |
1982-10-12 |
Xerox Corporation |
Moving coil, multiple energy print hammer system including a closed loop servo
|
CY1492A
(en)
|
1981-07-08 |
1990-02-16 |
Draco Ab |
Powder inhalator
|
GR79615B
(es)
|
1982-10-08 |
1984-10-31 |
Glaxo Group Ltd |
|
GB2169265B
(en)
|
1982-10-08 |
1987-08-12 |
Glaxo Group Ltd |
Pack for medicament
|
US4778054A
(en)
|
1982-10-08 |
1988-10-18 |
Glaxo Group Limited |
Pack for administering medicaments to patients
|
US4775761A
(en)
*
|
1983-08-22 |
1988-10-04 |
Hoechst-Roussel Pharmaceuticals, Inc. |
3-(piperidinyl)- and 3-(pyrrolidinyl)-1H-indazoles
|
US5256673A
(en)
|
1983-11-25 |
1993-10-26 |
Merck Patent Gesellschaft Mit Beschrankter Haftung |
Indole-3-yl-A-tetrahydropyridyl or piperidyl compounds
|
DE3342632A1
(de)
|
1983-11-25 |
1985-06-05 |
Merck Patent Gmbh, 6100 Darmstadt |
Indolderivate
|
PH26882A
(en)
|
1985-07-30 |
1992-11-16 |
Glaxo Group Ltd |
Devices for administering medicaments to patients
|
ES2059408T3
(es)
|
1987-02-10 |
1994-11-16 |
Abbott Lab |
Un proceso para la preparacion de un compuesto.
|
JPH0262875A
(ja)
*
|
1988-05-23 |
1990-03-02 |
Wakunaga Pharmaceut Co Ltd |
新規イソインドリン誘導体
|
IL95584A
(en)
|
1989-09-07 |
1995-03-15 |
Abbott Lab |
Indole-, benzoporene- and benzothiophene compounds including lipoxygenase-inhibiting compounds and pharmaceutical compounds containing them
|
GB9004781D0
(en)
|
1990-03-02 |
1990-04-25 |
Glaxo Group Ltd |
Device
|
US5254473A
(en)
|
1990-03-16 |
1993-10-19 |
Jp Laboratories |
Solid state device for monitoring integral values of time and temperature of storage of perishables
|
GB9127376D0
(en)
|
1991-12-24 |
1992-02-19 |
Wellcome Found |
Amidino derivatives
|
JP2963288B2
(ja)
|
1992-01-14 |
1999-10-18 |
株式会社海洋バイオテクノロジー研究所 |
水中有害付着生物防除剤
|
SK279958B6
(sk)
|
1992-04-02 |
1999-06-11 |
Smithkline Beecham Corporation |
Zlúčeniny s protialergickým a protizápalovým účink
|
US5256873A
(en)
*
|
1992-09-03 |
1993-10-26 |
Eaton Corporation |
Multiple station through beam photoelectric sensor
|
US5330986A
(en)
|
1992-11-24 |
1994-07-19 |
Hoechst-Roussel Pharmaceuticals Inc. |
Indole-7-carboxamide derivatives
|
FR2701026B1
(fr)
|
1993-02-02 |
1995-03-31 |
Adir |
Nouveaux dérivés de l'indole, de l'indazole et du benzisoxazole, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
|
GB9305623D0
(en)
|
1993-03-18 |
1993-05-05 |
Merck Sharp & Dohme |
Therapeutic agents
|
AU6215594A
(en)
|
1993-03-18 |
1994-10-11 |
Merck Sharp & Dohme Limited |
Indole derivatives as dopamine d4 antagonists
|
EP0707585A1
(en)
*
|
1993-07-06 |
1996-04-24 |
Pfizer Inc. |
Bicyclic tetrahydro pyrazolopyridines
|
WO1995034534A1
(en)
|
1994-06-15 |
1995-12-21 |
The Wellcome Foundation Limited |
Enzyme inhibitors
|
ZA951822B
(en)
|
1994-12-23 |
1996-09-26 |
Glaxo Group Ltd |
Chemical compounds
|
DE19500689A1
(de)
|
1995-01-12 |
1996-07-18 |
Merck Patent Gmbh |
Indolpiperidin-Derivate
|
DE69609315T2
(de)
|
1995-03-10 |
2001-02-15 |
Minnesota Mining & Mfg |
Ventil für aerosolbehälter
|
EP0831809A4
(en)
|
1995-06-07 |
2001-11-28 |
Sugen Inc |
METHODS AND COMPOUNDS FOR INHIBITING ADAPTIVE PROTEIN / TYROSINE KINASE INTERACTIONS
|
GB9610811D0
(en)
|
1996-05-23 |
1996-07-31 |
Pharmacia Spa |
Combinatorial solid phase synthesis of a library of indole derivatives
|
US5846982A
(en)
|
1996-06-14 |
1998-12-08 |
Eli Lilly And Company |
Inhibition of serotonin reuptake
|
EP1077213A3
(en)
|
1996-06-14 |
2001-06-13 |
Eli Lilly And Company |
Inhibition of serotonin reuptake
|
WO1998006715A1
(en)
|
1996-08-09 |
1998-02-19 |
Smithkline Beecham Corporation |
Novel piperazine containing compounds
|
GB9700226D0
(en)
|
1997-01-08 |
1997-02-26 |
Glaxo Group Ltd |
Inhalation device
|
MY117948A
(en)
|
1997-01-13 |
2004-08-30 |
Glaxo Group Ltd |
Nitride oxide synthase inhibitors.
|
DE19723722A1
(de)
|
1997-05-30 |
1998-12-10 |
Schering Ag |
Nichtsteroidale Gestagene
|
PL338453A1
(en)
|
1997-08-06 |
2000-11-06 |
Lilly Co Eli |
2-acylaminopropanoamines as antagonists of the tachykinin receptor
|
WO1999016766A1
(fr)
|
1997-10-01 |
1999-04-08 |
Kyowa Hakko Kogyo Co., Ltd. |
Derives de benzodioxole
|
AR013669A1
(es)
|
1997-10-07 |
2001-01-10 |
Smithkline Beecham Corp |
Compuestos y metodos
|
DE19756036A1
(de)
|
1997-12-17 |
1999-06-24 |
Merck Patent Gmbh |
Amid- und Harnstoffderivate
|
JP2002515891A
(ja)
|
1997-12-19 |
2002-05-28 |
スミスクライン・ビーチャム・コーポレイション |
新規なピペリジン含有化合物
|
US6506766B1
(en)
|
1998-02-13 |
2003-01-14 |
Abbott Laboratories |
Glucocortiocoid-selective antinflammatory agents
|
DE19807993A1
(de)
|
1998-02-26 |
1999-09-02 |
Bayer Ag |
Verwendung von ß-Carbolinderivaten zur Bekämpfung von TNF-alpha-abhängigen Krankheiten
|
WO1999043652A1
(fr)
|
1998-02-27 |
1999-09-02 |
Kissei Pharmaceutical Co., Ltd. |
Derives de l'indole et compositions medicales les renfermant
|
AU3328499A
(en)
|
1998-03-14 |
1999-10-11 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Phthalazinone pde iii/iv inhibitors
|
US6589954B1
(en)
*
|
1998-05-22 |
2003-07-08 |
Scios, Inc. |
Compounds and methods to treat cardiac failure and other disorders
|
GB9811599D0
(en)
|
1998-05-30 |
1998-07-29 |
Glaxo Group Ltd |
Nitric oxide synthase inhibitors
|
EP1089993B1
(en)
|
1998-06-30 |
2003-10-22 |
Eli Lilly And Company |
5-ht1f agonists
|
SI1194425T1
(sl)
|
1999-06-23 |
2005-12-31 |
Sanofi Aventis Deutschland |
Substituirani benzimidazoli
|
DE19928424A1
(de)
|
1999-06-23 |
2000-12-28 |
Aventis Pharma Gmbh |
Substituierte Benzimidazole
|
ES2165768B1
(es)
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
|
MXPA02001568A
(es)
*
|
1999-08-13 |
2002-07-02 |
Vela Pharmaceuticals Inc |
Ciclobenzaprina para tratar trastornos de ansiedad generalizada y composiciones de la misma.
|
CO5180649A1
(es)
|
1999-09-01 |
2002-07-30 |
Abbott Lab |
Antagonistas de los receptores de los glucocorticoides para el tratamiento de la diabetes para el tratamiento de la diabetes
|
DE19951360A1
(de)
|
1999-10-26 |
2001-05-03 |
Aventis Pharma Gmbh |
Substituierte Indole
|
US6245799B1
(en)
*
|
1999-11-08 |
2001-06-12 |
American Home Products Corp |
[(Indol-3-yl)-cycloalkyl]-3-substituted azetidines for the treatment of central nervous system disorders
|
BR0015401A
(pt)
|
1999-11-08 |
2002-07-02 |
Wyeth Corp |
[(indol-3-il)-cicloalquil]-3-azetidinas substituìdas para o tratamento de distúrbios do sistema nervoso central
|
OA11558A
(en)
|
1999-12-08 |
2004-06-03 |
Advanced Medicine Inc |
Beta 2-adrenergic receptor agonists.
|
US6632666B2
(en)
|
2000-01-14 |
2003-10-14 |
Biolife Solutions, Inc. |
Normothermic, hypothermic and cryopreservation maintenance and storage of cells, tissues and organs in gel-based media
|
GB0003154D0
(en)
|
2000-02-12 |
2000-04-05 |
Astrazeneca Uk Ltd |
Novel compounds
|
EP1209158A1
(en)
|
2000-11-18 |
2002-05-29 |
Aventis Pharma Deutschland GmbH |
Substituted beta-carbolines
|
EP1268477B1
(en)
|
2000-03-15 |
2010-04-21 |
Sanofi-Aventis Deutschland GmbH |
Substituted beta-carbolines with ikb-kinase inhibiting activity
|
EP1134221A1
(en)
|
2000-03-15 |
2001-09-19 |
Aventis Pharma Deutschland GmbH |
Substituted beta-carbolines as lkB kinase inhibitors
|
AU2001255538B2
(en)
*
|
2000-04-24 |
2006-03-30 |
Bristol-Myers Squibb Company |
Heterocycles that are inhibitors of IMPDH enzyme
|
JP4119126B2
(ja)
|
2000-04-28 |
2008-07-16 |
アカディア ファーマシューティカルズ,インコーポレーテッド |
ムスカリン性アゴニスト
|
US6849655B2
(en)
|
2000-05-15 |
2005-02-01 |
Kissei Pharmaceutical Co., Ltd. |
Aqueous liquid formulations
|
US6414013B1
(en)
|
2000-06-19 |
2002-07-02 |
Pharmacia & Upjohn S.P.A. |
Thiophene compounds, process for preparing the same, and pharmaceutical compositions containing the same background of the invention
|
US6897231B2
(en)
|
2000-07-31 |
2005-05-24 |
Signal Pharmaceuticals, Inc. |
Indazole derivatives as JNK inhibitors and compositions and methods related thereto
|
US20050009876A1
(en)
|
2000-07-31 |
2005-01-13 |
Bhagwat Shripad S. |
Indazole compounds, compositions thereof and methods of treatment therewith
|
AU7576001A
(en)
|
2000-08-05 |
2002-02-18 |
Glaxo Group Ltd |
6.alpha., 9.alpha.-difluoro-17.alpha.-`(2-furanylcarboxyl) oxy]-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent
|
NZ524192A
(en)
|
2000-08-14 |
2005-02-25 |
Ortho Mcneil Pharm Inc |
Substituted pyrazoles
|
WO2002016353A1
(en)
|
2000-08-17 |
2002-02-28 |
Celltech R & D Limited |
Bicyclic heteroaromatic derivatives for the treatment of immune and inflammatory disorders
|
US6868504B1
(en)
*
|
2000-08-31 |
2005-03-15 |
Micron Technology, Inc. |
Interleaved delay line for phase locked and delay locked loops
|
WO2002020002A2
(en)
*
|
2000-09-06 |
2002-03-14 |
Ortho Mcneil Pharmaceutical, Inc. |
A method for treating allergies
|
JP4272338B2
(ja)
|
2000-09-22 |
2009-06-03 |
バイエル アクチェンゲゼルシャフト |
ピリジン誘導体
|
AU2001290143A1
(en)
|
2000-09-29 |
2002-04-08 |
Glaxo Group Limited |
Morpholin-acetamide derivatives for the treatment of inflammatory diseases
|
AU2002211827B2
(en)
|
2000-10-03 |
2006-12-14 |
Bristol-Myers Squibb Company |
Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same
|
US6869956B2
(en)
*
|
2000-10-03 |
2005-03-22 |
Bristol-Myers Squibb Company |
Methods of treating inflammatory and immune diseases using inhibitors of IκB kinase (IKK)
|
WO2002030353A2
(en)
|
2000-10-12 |
2002-04-18 |
Smithkline Beecham Corporation |
NF-λB INHIBITORS
|
EP1328272A1
(en)
|
2000-10-12 |
2003-07-23 |
SmithKline Beecham Corporation |
Nf-kappa-b inhibitors
|
EP1333834B1
(en)
|
2000-10-26 |
2008-04-23 |
Amgen Inc. |
Antiinflammation agents
|
JP2002193938A
(ja)
|
2000-12-01 |
2002-07-10 |
Bayer Ag |
4−アリールピリジン誘導体
|
US7122544B2
(en)
|
2000-12-06 |
2006-10-17 |
Signal Pharmaceuticals, Llc |
Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto
|
GB0031179D0
(en)
|
2000-12-21 |
2001-01-31 |
Glaxo Group Ltd |
Nitric oxide synthase inhibitors
|
DE60129746T2
(de)
|
2000-12-22 |
2008-04-30 |
Wyeth |
Hetorocyclindazole und -azaindazole verbindungen als 5-hydroxytryptamine-6 liganden
|
US6484903B2
(en)
|
2001-01-09 |
2002-11-26 |
Riverwood International Corporation |
Carton with an improved dispensing feature in combination with a unique handle
|
HUP0304045A3
(en)
|
2001-02-01 |
2005-05-30 |
Bristol Myers Squibb Company P |
Use of ikb-kinase inhibitors for treating of inflammatory and immune diseases and pharmaceutical compositions containing them
|
GB0103630D0
(en)
|
2001-02-14 |
2001-03-28 |
Glaxo Group Ltd |
Chemical compounds
|
ATE365720T1
(de)
|
2001-03-08 |
2007-07-15 |
Glaxo Group Ltd |
Agonisten von beta-adrenorezeptoren
|
DE10112151A1
(de)
|
2001-03-14 |
2002-09-19 |
Merck Patent Gmbh |
Substituierte Benzofuran-2-carbonsäureamide
|
JP4143413B2
(ja)
|
2001-03-22 |
2008-09-03 |
グラクソ グループ リミテッド |
β2−アドレナリン受容体アゴニストとしてのホルムアニリド誘導体
|
EP1383786B1
(en)
|
2001-04-30 |
2008-10-15 |
Glaxo Group Limited |
Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
|
WO2002094265A1
(en)
|
2001-05-24 |
2002-11-28 |
Leo Pharma A/S |
A method of modulating nf-$g(k)b activity
|
US20030045515A1
(en)
|
2001-05-24 |
2003-03-06 |
Lise Binderup |
Combination medicament for treatment of neoplastic diseases
|
WO2002094813A1
(en)
|
2001-05-24 |
2002-11-28 |
Leo Pharma A/S |
Novel pyridyl cyanoguanidine compounds
|
WO2002098857A1
(en)
|
2001-06-07 |
2002-12-12 |
F. Hoffmann-La Roche Ag |
New indole derivatives with 5-ht6 receptor affinity
|
DE60227254D1
(de)
|
2001-06-12 |
2008-08-07 |
Glaxo Group Ltd |
Neue anti inflammatorische 17.alpha.-heterozyklische ester von 17.beta.-carbothioat androstan derivativen
|
US6638679B2
(en)
|
2001-07-12 |
2003-10-28 |
Kodak Polychrome Graphics, Llc |
Photosensitive compositions having mixtures of alkoxy and non-alkoxy diazonium salt containing compounds
|
SE0102616D0
(sv)
|
2001-07-25 |
2001-07-25 |
Astrazeneca Ab |
Novel compounds
|
SE0102617D0
(sv)
|
2001-07-25 |
2001-07-25 |
Astrazeneca Ab |
Novel compounds
|
US20030127204A1
(en)
|
2001-09-06 |
2003-07-10 |
Varnell Daniel F. |
Amphoteric polymer resins that increase the rate of sizing development
|
ES2316599T3
(es)
|
2001-09-14 |
2009-04-16 |
Glaxo Group Limited |
Derivados de fenetanolamina para el tratamiento de enfermedades respiratorias.
|
ES2286275T3
(es)
|
2001-09-19 |
2007-12-01 |
Pharmacia Corporation |
Compuestos de pirazolo sustituidos para el tratamiento de la inflamacion.
|
EP1427707A1
(en)
|
2001-09-19 |
2004-06-16 |
Pharmacia Corporation |
Substituted indazole compounds for the treatment of inflammation
|
BR0212661A
(pt)
|
2001-09-19 |
2004-08-24 |
Pharmacia Corp |
Compostos de pirazolil benzenossulfamida substituìdos para o tratamento de inflamação
|
JP2005506983A
(ja)
|
2001-09-19 |
2005-03-10 |
ファルマシア・コーポレーション |
炎症の治療のための置換ピラゾリル化合物
|
WO2003037886A2
(en)
|
2001-10-30 |
2003-05-08 |
Pharmacia Corporation |
Heteroaromatic carboxamide derivatives for the treatment of inflammation
|
WO2003042160A1
(en)
|
2001-11-13 |
2003-05-22 |
Theravance, Inc. |
Aryl aniline beta-2 adrenergic receptor agonists
|
DE60309829T2
(de)
|
2002-01-14 |
2007-09-13 |
Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield |
Glucocorticoidmimetika, verfahren zu ihrer herstellung, diese enthaltende pharmazeutische formulierungen und ihre verwendungen
|
CA2473886C
(en)
|
2002-01-22 |
2012-08-21 |
The Regents Of The University Of California |
Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof
|
US6646785B2
(en)
|
2002-01-31 |
2003-11-11 |
Corning Incorporated |
Fiber ring amplifiers and lasers
|
ATE329581T1
(de)
|
2002-02-14 |
2006-07-15 |
Glaxo Group Ltd |
Pharmazeutische formulierung, die n-((1-n-butyl-4-piperidinyl)menthyl)-3,4-dihydr -2h-(1, 3)oxazino(3,2-a)indol-10-carboxamid oder ein entsprechendes salz hiervon enthält, sowie deren herstellungsprozess, welcher trockengranulierung beinhaltet
|
GB0204719D0
(en)
|
2002-02-28 |
2002-04-17 |
Glaxo Group Ltd |
Medicinal compounds
|
EP1490062B1
(en)
|
2002-03-26 |
2007-12-19 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
AU2003230700A1
(en)
|
2002-03-26 |
2003-10-13 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
DE10215316C1
(de)
|
2002-04-02 |
2003-12-18 |
Schering Ag |
Chinolin- und Isochinolin-Derivate, ein pharmazeutisches Mittel und ihre Verwendung als Entzündungshemmer
|
ES2291628T3
(es)
|
2002-04-03 |
2008-03-01 |
Bristol-Myers Squibb Company |
Compuestos triciclicos a base de tiofeno y composiciones farmaceuticas que comprenden dichos compuestos.
|
EP1495016A2
(en)
|
2002-04-09 |
2005-01-12 |
Astex Technology Limited |
Heterocyclic compounds and their use as modulators of p38 map kinase
|
TW200403991A
(en)
|
2002-04-11 |
2004-03-16 |
Smithkline Beecham Corp |
NF-κb inhibitors
|
US7282591B2
(en)
|
2002-04-11 |
2007-10-16 |
Merck & Co., Inc. |
1h-benzo{f}indazol-5-yl derivatives as selective glucocorticoid receptor modulators
|
EP1497261B1
(en)
|
2002-04-25 |
2007-12-19 |
Glaxo Group Limited |
Phenethanolamine derivatives
|
AU2003220483A1
(en)
|
2002-05-09 |
2003-11-11 |
Pharmacia Corporation |
Substituted pyrazolyl compounds for the treatment of inflammation
|
US7186864B2
(en)
|
2002-05-29 |
2007-03-06 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
DE60307102T2
(de)
|
2002-05-30 |
2006-12-07 |
Neurosearch A/S |
3-substituierte chinuclidine und ihre verwendung
|
CN100386329C
(zh)
|
2002-06-06 |
2008-05-07 |
贝林格尔.英格海姆药物公司 |
取代的3-氨基-噻吩并[2,3-b]吡啶-2-羧酸酰胺化合物及其制备方法和用途
|
US7074806B2
(en)
|
2002-06-06 |
2006-07-11 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
WO2003104218A1
(en)
|
2002-06-06 |
2003-12-18 |
Smithkline Beecham Corporation |
Nf-:b inhibitors
|
AU2003281355A1
(en)
|
2002-07-08 |
2004-01-23 |
Pfizer Products Inc. |
Modulators of the glucocorticoid receptor
|
AU2003251970A1
(en)
|
2002-07-18 |
2004-02-09 |
Bristol-Myers Squibb Company |
Modulators of the glucocorticoid receptor and method
|
GB0217225D0
(en)
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicinal compounds
|
DE10237722A1
(de)
|
2002-08-17 |
2004-08-19 |
Aventis Pharma Deutschland Gmbh |
Indol- oder Benzimidazolderivate zur Modulation der IKappaB-Kinase
|
EP1532113B1
(en)
|
2002-08-21 |
2008-08-06 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Substituted hihydroquinolines as glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
JP4619786B2
(ja)
|
2002-08-29 |
2011-01-26 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
炎症性、アレルギー性及び増殖性疾患の治療において糖質コルチコイドミメティックスとして使用するための3−(スルホンアミドエチル)−インドール誘導体
|
GB0220730D0
(en)
|
2002-09-06 |
2002-10-16 |
Glaxo Group Ltd |
Medicinal compounds
|
US6911445B2
(en)
|
2002-09-12 |
2005-06-28 |
Wyeth |
Antidepressant cycloalkylamine derivatives of heterocycle-fused benzodioxans
|
US7135479B2
(en)
|
2002-09-12 |
2006-11-14 |
Wyeth |
Antidepressant azaheterocyclylmethyl derivatives of heterocycle-fused benzodioxans
|
US6919334B2
(en)
|
2002-09-12 |
2005-07-19 |
Wyeth |
Antidepressant azaheterocyclymethyl derivatives of 4,5-dihydroimidazo[1,4,5-de][1,4]benzoxazine
|
CA2497550A1
(en)
|
2002-09-16 |
2004-03-25 |
Glaxo Group Limited |
Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors
|
GB0230045D0
(en)
|
2002-12-23 |
2003-01-29 |
Glaxo Group Ltd |
Compounds
|
WO2004026248A2
(en)
|
2002-09-20 |
2004-04-01 |
Merck & Co., Inc. |
Octahydro-2-h-naphtho[1,2-f] indole-4-carboxamide derivatives as selective glucocorticoid receptor modulators
|
GB0224084D0
(en)
|
2002-10-16 |
2002-11-27 |
Glaxo Group Ltd |
Novel compounds
|
AU2003298094A1
(en)
|
2002-10-22 |
2004-05-13 |
Glaxo Group Limited |
Medicinal arylethanolamine compounds
|
GB0225030D0
(en)
|
2002-10-28 |
2002-12-04 |
Glaxo Group Ltd |
Medicinal compounds
|
DE60320007T2
(de)
|
2002-10-28 |
2009-06-18 |
Glaxo Group Ltd., Greenford |
Phenthanolamin-Derivate zur Behandlung von Atemwegserkrankungen
|
GB0225540D0
(en)
|
2002-11-01 |
2002-12-11 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0225535D0
(en)
|
2002-11-01 |
2002-12-11 |
Glaxo Group Ltd |
Medicinal compounds
|
CA2507074A1
(en)
|
2002-12-02 |
2004-06-17 |
F. Hoffmann-La Roche Ag |
Indazole derivatives as crf antagonists
|
US20060116419A1
(en)
|
2002-12-06 |
2006-06-01 |
Callahan James F |
Nf-kb inhibitors
|
DE10259244A1
(de)
|
2002-12-17 |
2004-07-01 |
Merck Patent Gmbh |
N-(Indolethyl-)cycloamin-Verbindungen
|
US7329668B2
(en)
|
2003-02-25 |
2008-02-12 |
Bristol-Myers Squibb Company |
Pyrazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same
|
GB0308466D0
(en)
|
2003-04-11 |
2003-05-21 |
Novartis Ag |
Organic compounds
|
TWI328009B
(en)
|
2003-05-21 |
2010-08-01 |
Glaxo Group Ltd |
Quinoline derivatives as phosphodiesterase inhibitors
|
US7176214B2
(en)
|
2003-05-21 |
2007-02-13 |
Bristol-Myers Squibb Company |
Imidazo-fused oxazolo[4,5-β]pyridine and imidazo-fused thiazolo[4,5-β]pyridine based tricyclic compounds and pharmaceutical compositions comprising same
|
GB0316290D0
(en)
|
2003-07-11 |
2003-08-13 |
Glaxo Group Ltd |
Novel compounds
|
CA2534127A1
(en)
|
2003-07-31 |
2005-02-10 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Substituted benzothiophene compounds and uses thereof
|
US7291733B2
(en)
|
2003-10-10 |
2007-11-06 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Substituted tricyclic heterocycles and their uses
|
MXPA06003746A
(es)
|
2003-10-14 |
2006-06-14 |
Pharmacia Corp |
Compuestos de pirazinona sustituida para el tratamiento de inflamacion.
|
AP2007004238A0
(en)
|
2003-10-14 |
2007-12-31 |
Glaxo Group Ltd |
Muscarinic acetycholine receptor antagonists
|
AR046225A1
(es)
|
2003-11-04 |
2005-11-30 |
Glaxo Group Ltd |
Compuesto de 8-azoniabiciclo(3.2.1)octano, composicion farmaceutica para el tratamiento de enfermedades mediadas por receptores de acetilcolina muscarinicos que lo comprende y uso del compuesto para preparar dicha composicion
|
CA2546493A1
(en)
|
2003-11-19 |
2005-06-09 |
Signal Pharmaceuticals, Llc |
Indazole compounds and methods of use thereof as protein kinase inhibitors
|
AU2004299277A1
(en)
|
2003-12-19 |
2005-06-30 |
Glaxo Group Limited |
Pyrazolo (3,4-b) pyridine compounds, and their use as phosphodiesterase inhibitors
|
EP1694686A1
(en)
|
2003-12-19 |
2006-08-30 |
Takeda San Diego, Inc. |
Kinase inhibitors
|
GB0400895D0
(en)
|
2004-01-15 |
2004-02-18 |
Smithkline Beecham Corp |
Chemical compounds
|
DE102004012069A1
(de)
|
2004-03-12 |
2005-09-29 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue aryl-haltige 5-Acylindolinone, deren Herstellung und deren Verwendung als Arzneimittel
|
JP2007529464A
(ja)
|
2004-03-16 |
2007-10-25 |
グラクソ グループ リミテッド |
ビラゾロ[3,4−b]ピリジン化合物及びPDE4阻害剤としてのその使用
|
GB0405937D0
(en)
|
2004-03-16 |
2004-04-21 |
Glaxo Group Ltd |
Compounds
|
GB0405933D0
(en)
|
2004-03-16 |
2004-04-21 |
Glaxo Group Ltd |
Compounds
|
UY28871A1
(es)
|
2004-04-27 |
2005-11-30 |
Glaxo Group Ltd |
Antagonistas del receptor de acetilcolina muscarinico
|
TW200616967A
(en)
*
|
2004-06-24 |
2006-06-01 |
Smithkline Beecham Corp |
Novel indazole carboxamides and their use
|
WO2006000398A1
(en)
|
2004-06-28 |
2006-01-05 |
Glaxo Group Limited |
2,3-benzoxazin derivatives as non-steroidal glucocorticoid receptor modulators
|
WO2006000401A1
(en)
|
2004-06-28 |
2006-01-05 |
Glaxo Group Limited |
Substituted oxazines as glucocorticoid receptor modulators
|
GB0418045D0
(en)
|
2004-08-12 |
2004-09-15 |
Glaxo Group Ltd |
Compounds
|
PE20060748A1
(es)
*
|
2004-09-21 |
2006-10-01 |
Smithkline Beecham Corp |
Derivados de indolcarboxamida como inhibidores de quinasa ikk2
|
AU2005299018B2
(en)
|
2004-10-19 |
2011-07-07 |
F. Hoffmann-La Roche Ag |
Quinoline derivatives
|
ATE517908T1
(de)
|
2005-01-10 |
2011-08-15 |
Glaxo Group Ltd |
Androstan-17-alpha-carbonat-derivate zur verwendung bei der behandlung allergischer und entzündlicher zustände
|
US20090124588A1
(en)
|
2005-01-10 |
2009-05-14 |
Glaxo Group Limited |
Androstane 17-Alpha-Carbonate for Use in the Treatment of Inflammatory and Allergic Conditions
|
MX2007012448A
(es)
|
2005-04-06 |
2007-10-19 |
Astrazeneca Ab |
Heterociclos sustituidos y su uso como inhibidores de chk1, pdk1 y pak.
|
KR20130136010A
(ko)
|
2005-04-13 |
2013-12-11 |
네우렉슨 인코포레이티드 |
Nos 저해 활성을 갖는 치환된 인돌 화합물
|
JP2009507746A
(ja)
|
2005-06-14 |
2009-02-26 |
コンストラクション リサーチ アンド テクノロジー ゲーエムベーハー |
セメント状組成物に耐凍性および融解抵抗性を付与する方法
|
US8063071B2
(en)
*
|
2007-10-31 |
2011-11-22 |
GlaxoSmithKline, LLC |
Chemical compounds
|
JP5059756B2
(ja)
|
2005-06-30 |
2012-10-31 |
グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー |
化合物
|
WO2007010964A1
(ja)
|
2005-07-22 |
2007-01-25 |
Shionogi & Co., Ltd. |
Pgd2受容体アンタゴニスト活性を有するインドール誘導体
|
JP2009513677A
(ja)
|
2005-10-25 |
2009-04-02 |
スミスクライン・ビーチャム・コーポレイション |
化合物
|
US20080242685A1
(en)
|
2005-10-25 |
2008-10-02 |
Smithkline Beecham Corporation |
Chemical Compounds
|
US20080269291A1
(en)
*
|
2005-11-18 |
2008-10-30 |
Kerns Jeffrey K |
Chemical Compounds
|
US20080293802A1
(en)
*
|
2005-12-16 |
2008-11-27 |
Smithline Beecham Corporation |
Chemical Compounds
|
MX2008012482A
(es)
|
2006-03-31 |
2008-10-10 |
Abbott Lab |
Compuestos de indazol.
|
ATE493411T1
(de)
|
2006-09-22 |
2011-01-15 |
Glaxo Group Ltd |
Pyrroloä2, 3-büpyridin-4-yl- benzolsulfonamidverbindungen als ikk2-hemmer
|
PE20081889A1
(es)
|
2007-03-23 |
2009-03-05 |
Smithkline Beecham Corp |
Indol carboxamidas como inhibidores de ikk2
|
GB0710528D0
(en)
|
2007-06-01 |
2007-07-11 |
Glaxo Group Ltd |
Novel compounds
|
GB0804592D0
(en)
|
2008-03-12 |
2008-04-16 |
Glaxo Group Ltd |
Novel compounds
|
US8354539B2
(en)
|
2009-03-10 |
2013-01-15 |
Glaxo Group Limited |
Indole derivatives as IKK2 inhibitors
|
JP2012520845A
(ja)
|
2009-03-17 |
2012-09-10 |
グラクソ グループ リミテッド |
Itk阻害剤として使用されるピリミジン誘導体
|